Dose escalation in oesophageal cancer: comparing pre-accrual SCOPE2/PRODIGE-26 RTTQA programmes

被引：0
|
作者：
Helbrow, J. [1 ]
Nicholas, O. [1 ]
Lewis, G. [2 ]
Radhakrishna, G. [3 ]
Crosby, T. [4 ]
Gwynne, S. [1 ,5 ]
机构：
[1] South West Wales Canc Ctr, Clin Oncol, Swansea, Wales
[2] Velindre Canc Ctr, Med Phys, Cardiff, Wales
[3] The Christie, Clin Oncol, Manchester, Lancs, England
[4] Velindre Canc Ctr, Clin Oncol, Cardiff, Wales
[5] Swansea Univ, Med Sch, Swansea, W Glam, Wales
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-0490
引用
收藏
页码：S398 / S399
页数：2
相关论文
共 5 条
  • [1] Dose escalation in oesophageal cancer: comparing inter-reviewer variation within the UK SCOPE2 trial
    Helbrow, Jonathan
    Crosby, Tom
    Nicholas, Owen
    Radhakrishna, Ganesh
    Graby, John
    Lewis, Geraint J.
    Cox, Samantha
    Hawkins, Maria
    Evans, Rhiannon M.
    Gwynne, Sarah
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5871 - S5873
  • [2] A qualitative study exploring participants' experiences of the SCOPE2 trial: chemoradiotherapy dose escalation in oesophageal cancer
    Holland-Hart, Daniella
    Longo, Mirella
    Bridges, Sarah
    Nixon, Lisette
    Hawkins, Maria
    Crosby, Tom
    Nelson, Annmarie
    TRIALS, 2025, 26 (01)
  • [3] Exclusive Chemoradiotherapy With or Without Radiation Dose Escalation in Esophageal Cancer: Multicenter Phase 2/3 Randomized Trial CONCORDE (PRODIGE-26)
    Crehange, G.
    M'vondo, C.
    Bertaut, A.
    Pereira, R.
    Rio, E.
    Peiffert, D.
    Gnep, K.
    Benezery, K.
    Ronchin, P.
    Noel, G.
    Mineur, L.
    Drouillard, A.
    Blanc, J.
    Rouffiac, M.
    Boustani, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S5 - S5
  • [4] Dose Escalation in Esophageal Cancer: Comparing PreAccrual and On-Trial Target Volume Delineation in the UK SCOPE2 Trial
    Helbrow, J.
    Graby, J.
    Lewis, G.
    Cox, S.
    Nicholas, O.
    Radhakrishna, G.
    Crosby, T.
    Gwynne, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E301 - E302
  • [5] SCOPE 2-Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography
    Bridges, S.
    Thomas, B.
    Radhakrishna, G.
    Hawkins, M.
    Holborow, A.
    Hurt, C.
    Mukherjee, S.
    Nixon, L.
    Crosby, T.
    Gwynne, S.
    CLINICAL ONCOLOGY, 2022, 34 (07) : E269 - E280
1